Cargando…

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer

BACKGROUND: Debates exist on the treatment decision of the stage II/III colorectal cancer (CRC) due to the insufficiency of the current TNM stage‐based risk stratification system. Epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME) have both been linked to CRC progression in rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Du, Wang, Wei, Zhong, Min‐Er, Fan, Dejun, Liu, Xuanhui, Li, Cheng‐Hang, Huang, Ze‐Ping, Zhu, Qiqi, Lv, Min‐Yi, Hu, Chuling, Duan, Xin, Wu, Xiao‐Jian, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134284/ https://www.ncbi.nlm.nih.gov/pubmed/36629124 http://dx.doi.org/10.1002/cam4.5534

Ejemplares similares

DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
por: Lv, Min-Yi, et al.
Publicado: (2022)

Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer
por: Li, Cheng-Hang, et al.
Publicado: (2022)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer
por: Cai, Du, et al.
Publicado: (2021)

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020)

Mesenchymal stem cells induce tumor stroma formation and epithelial-mesenchymal transition through SPARC expression in colorectal cancer
por: Naito, Toshikatsu, et al.
Publicado: (2021)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
por: Roepman, Paul, et al.
Publicado: (2014)

Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer Cells
por: Franchi, Marco, et al.
Publicado: (2019)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

Atractylenolide III inhibits epithelial-mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway
por: Huang, Mingjin, et al.
Publicado: (2022)

High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma
por: Sánchez-Ramírez, Damián, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma
por: Yang, XinJie, et al.
Publicado: (2021)

A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer
por: Zhou, Rui, et al.
Publicado: (2020)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
por: del Pozo Martin, Yaiza, et al.
Publicado: (2015)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
por: Xu, Bang-Hao, et al.
Publicado: (2021)

The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
por: Liu, Qiqi, et al.
Publicado: (2016)

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
por: De Wever, Olivier, et al.
Publicado: (2008)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
por: Yang, Dong, et al.
Publicado: (2023)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
por: Karkampouna, Sofia, et al.
Publicado: (2020)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Mesenchymal cells from limbal stroma of human eye
por: Polisetty, Naresh, et al.
Publicado: (2008)

Mesenchymal stroma/stem cells: Haematologists’ friend or foe?
por: Nachmias, Boaz, et al.
Publicado: (2022)

New highlights on stroma–epithelial interactions in breast cancer
por: Barcellos-Hoff, Mary Helen, et al.
Publicado: (2005)

Identification of Gene Signatures and Expression Patterns During Epithelial-to-Mesenchymal Transition From Single-Cell Expression Atlas
por: Yu, Xiangtian, et al.
Publicado: (2021)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

TGF-β2 Induces Epithelial–Mesenchymal Transitions in 2D Planer and 3D Spheroids of the Human Corneal Stroma Fibroblasts in Different Manners
por: Umetsu, Araya, et al.
Publicado: (2023)

Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy
por: Elzamly, Shaimaa, et al.
Publicado: (2018)

MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
por: Peng, Fu, et al.
Publicado: (2021)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
por: Zapperi, Stefano, et al.
Publicado: (2023)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

Mesenchymal stroma cells in peritoneal dialysis effluents from patients
por: Liu, Bin, et al.
Publicado: (2017)

Development of Foreign Mammary Epithelial Morphology in the Stroma of Immunodeficient Mice
por: Rauner, Gat, et al.
Publicado: (2013)

Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
por: Chen, Ying, et al.
Publicado: (2015)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
por: Zheng, Jia-Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_omvojohq3kt6jc1mns9tvch787